匯川技術(300124.SZ)半年度淨利預增95%-125%
格隆匯7月20日丨匯川技術(300124.SZ)披露半年度業績預吿,預計2021年半年度歸屬於上市公司股東的淨利潤151,016.50萬元–174,249.80萬元,同比增長95%-125%。
業績變動原因説明:
1、報吿期內,由於新基建投資拉動、產線自動化率提升、新能源乘用車普及率提高等原因,使得下游行業/客户對公司產品需求較為旺盛,公司通用自動化業務、新能源汽車業務、工業機器人業務均取得快速增長。
2、公司持續推進管理變革,使得運營效率有所提升。報吿期內,公司的銷售費用、研發費用、管理費用增速均低於收入增長速度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.